معرفی
Professor Alan Rowan serves as the Executive Institute Director of the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland, where he leads more than 500 researchers and professional staff. Since his appointment in 2016, Professor Rowan has championed partnerships that move research from the bench to business, driving the translation of scientific breakthroughs into real-world applications that help solve society's biggest problems. As a globally recognized leader in bioengineering and nanotechnology, he plays a central role in shaping the Institute's strategic direction and nurturing a culture of innovation.
- Bachelor (Honours) of Science (Advanced), University of Liverpool
- Doctor of Philosophy, University of Liverpool
Professor Rowan's research focuses on the interaction of cells with nanostructured materials and surfaces, particularly at the interface of chemistry, biology, and materials science. His groundbreaking work includes the development of the world's first biomimetic hydrogel that mimics the mechanical properties of human tissue - an innovation that has opened new possibilities in regenerative medicine, wound healing, and drug development. His research demonstrates how mechanical properties of biomaterials influence cellular behavior, with particular emphasis on stress-stiffening mechanisms in hydrogels and their impact on stem cell differentiation.
His recent publications show a clear progression from fundamental material science to targeted medical applications, with increasing focus on wound healing, vascular engineering, and sustainable biomaterials. The research demonstrates sophisticated integration of advanced imaging techniques with biomaterial design, particularly in understanding how specific biomolecules like hyaluronic acid influence disease processes and tissue regeneration.
- ARC Laureate Fellow
- Fellow of the Australian Academy of Science
- Chair of the Scientific Advisory Board for the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology
- Board member of the UQ Confucius Institute
- Board member of The Dow Centre for Sustainability
- Institute Director representative on UQ's Senior Executive Team
Professor Rowan has supervised over 55 PhD students to completion and is particularly passionate about supporting the next generation of scientist-entrepreneurs. His research is supported by substantial funding from diverse sources including the ARC Centre of Excellence in Quantum Biotechnology, Woodside Energy, NHMRC IDEAS Grants, and multiple U.S. Congressionally Directed Medical Research Programs. He has successfully translated research into practical applications through four startup companies: Encapson, Noviotech, NovioSense and Secmatix, demonstrating his commitment to moving discoveries from the laboratory to real-world impact.
As Director of AIBN, Professor Rowan oversees multiple research groups and facilities, including the Rowan Group which focuses on biomimetic materials and cell-matrix interactions. The institute maintains strong industry partnerships and collaborates with numerous research institutions globally, positioning Queensland as a leader in medtech innovation in the Asia-Pacific region. His current projects include Programming Synthetic Dendritic Cells, Combined confocal-rheology platform for studying ECM-cell interactions, and Wound Management: bioactivation of hydrogel to promote wound healing.
